Publications

Small EJ, Harris KA. Secondary hormonal manipulation of prostate cancer. Seminars in urologic oncology. 2002. PMID: 12198635

Harris KA, Weinberg V, Bok RA, Kakefuda M, Small EJ. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer. The Journal of urology. 2002. PMID: 12131305

Locher CP, Witt SA, Ashlock BM, Levy JA. Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element. DNA and cell biology. 2002. PMID: 12215261

Roumiantsev S, Shah NP, Gorre ME, Nicoll J, Brasher BB, Sawyers CL, Van Etten RA. Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Proceedings of the National Academy of Sciences of the United States of America. 2002. PMID: 12149456

Tan SL, Tareen SU, Melville MW, Blakely CM, Katze MG. The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. The Journal of biological chemistry. 2002. PMID: 12138106

Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood. 2002. PMID: 12393402

Kurizaki T, Okazaki S, Sanderson SD, Colcher D, Enke CA, Tempero MA, Baranowska-Kortylewicz J. Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2002. PMID: 12097469

Levy JA. HIV-1: hitching a ride on erythrocytes. Lancet (London, England). 2002. PMID: 12103280

Theodosiou A, Ashworth A. MAP kinase phosphatases. Genome biology. 2002. PMID: 12184814

Witt E, Ashworth A. Biomedicine. D-Day for BRCA2. Science (New York, N.Y.). 2002. PMID: 12065747

Castelli JC, Deeks SG, Shiboski S, Levy JA. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood. 2002. PMID: 12010831

Small EJ, Roach M. Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response. Seminars in oncology. 2002. PMID: 12063679

Harris KA, Harney E, Small EJ. Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer. Clinical prostate cancer. 2002. PMID: 15046711

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (London, England). 2002. PMID: 12004270

Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 12011123

Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010

Moasser MM, Rosen N. The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast cancer research and treatment. 2002. PMID: 12088116

Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141

Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. The Journal of urology. 2002. PMID: 11956415

Rini BI, Small EJ. Prostate cancer update. Current opinion in oncology. 2002. PMID: 11981273